Please assess the completion status of the following clinical trial:

Trial Title: Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* First-ever stroke according to the World Health Organisation criteria (previous transient ischaemic attack or clinically silent infarct on CT/MRI is not counted as previous stroke)~* CT/MRI scan required to classify ischaemic / haemorrhagic stroke~* Patient recruited 2-12 weeks after stroke~* Modified Ashworth Spasticity Score 1+ or above in either elbow or wrist joint~Exclusion Criteria:~* The patient has bleeding disturbances or having used coumarin derivatives~* The patient is currently receiving drugs affecting neuromuscular transmission~* Co-existing severe systemic illness which may adversely affect the functional outcome~* Pre-existing neuromuscular junction disease or any neurogenic disorders which can interfere with spasticity

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): Dysport
- 2 (Type: PLACEBO_COMPARATOR): Placebo

Based on this trial design, predict the completion outcome and termination type (if applicable).